Jun 3, 2025, 15:30
Effects of sickle trait on maternal and perinatal outcomes among pregnant women – Blood Vessels, Thrombosis & Hemostasis
Blood Vessels, Thrombosis & Hemostasis, the open-access journal of the American Society of Hematology, shares a compelling new study on X:
“New Blood Vessels, Thrombosis & Hemostasis issue out now featuring:
Effects of sickle trait on maternal and perinatal outcomes among pregnant women.”
This study underscores a critical association between sickle cell trait and elevated risks of adverse maternal and neonatal outcomes, including preeclampsia, low birth weight, and preterm delivery. The findings challenge traditional perceptions of SCT as benign in pregnancy and prompt reevaluation of antenatal surveillance strategies.
You can read a wide variety of new and diverse scientific posts in Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis